Preventive effects of different probiotic formulations on travelers' diarrhea model in wistar rats: Preventive effects of probiotics on TD

Digestive Diseases and Sciences

Volumn 55, Issue 4, 2010, Pages 911-919

  Bisson, Jean François ^a   Hidalgo, Sophie ^a   Rozan, Pascale ^a   Messaoudi, Michaël ^a  

^a Centre de Recherche en Pharmacologie   (France)

Author keywords

Escherichia coli; Prevention; Probiotics; Rat; Travelers' diarrhea

Indexed keywords

CYTOKINE; PLACEBO; PROBIOTIC AGENT; PROTECFLOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL STRAIN; BEHAVIOR; BODY TEMPERATURE; BODY WEIGHT; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG EFFECT; DRUG EFFICACY; ESCHERICHIA COLI INFECTION; FECES ANALYSIS; FLUID INTAKE; FOOD INTAKE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SACCHAROMYCES BOULARDII; SYMPTOM; TRAVELLER DIARRHEA; TREATMENT DURATION; TREATMENT RESPONSE; ANIMAL; BLOOD; COMPARATIVE STUDY; DIARRHEA; DISEASE MODEL; ENTEROTOXIGENIC ESCHERICHIA COLI; IMMUNOLOGY; ORAL DRUG ADMINISTRATION; PREMEDICATION; TRAVEL; WISTAR RAT;

ADMINISTRATION, ORAL; ANIMALS; CYTOKINES; DIARRHEA; DISEASE MODELS, ANIMAL; ENTEROTOXIGENIC ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; MALE; PREMEDICATION; PROBIOTICS; RATS; RATS, WISTAR; TRAVEL;

EID: 77950354453     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-009-0822-4     Document Type: Article

References (50)

1. J Yates 2005 Traveler's diarrhea Am Fam Physician 71 2095 2100 15952437
2. F Castelli N Saleri LR Tomasoni G Carosi 2006 Prevention and treatment of traveller's diarrhea. Focus on antimicrobial agents Digestion 73 109 118 10.1159/000089786 10.1159/000089786 16498259
3. F Guarner JR Matagelada 2003 Gut flora in health and disease Lancet 361 512 519 10.1016/S0140-6736(03)12489-0 10.1016/S0140-6736(03)12489-0 12583961 (Pubitemid 36173720)
4. AJ Roe DL Gally 2000 Enteropathogenic and enterohemorrhagic Escherichia coli and diarrhoea Curr Opin Infect Dis 13 511 517 10.1097/00001432-200010000- 00013 10.1097/00001432-200010000-00013 1:CAS:528:DC%2BD3cXosVeit7k%3D 11964822
5. DJ Diemert 2006 Prevention and self-treatment of traveler's diarrhea Clin Microbiol Rev 19 583 594 10.1128/CMR.00052-05 10.1128/CMR.00052-05 16847088 (Pubitemid 44134312)
6. HL DuPont 2007 Therapy for and prevention of traveler's diarrhea Clin Infect Dis 45 78 84 10.1086/518155 10.1086/518155 (Pubitemid 47036031)
7. AG Billoo MA Memon SA Khaskheli G Murtaza K Iqbal MS Shekhani AQ Siddiqi 2006 Role of a probiotic (Saccharomyces boulardii) in management and prevention of diarrhoea World J Gastroenterol 12 4557 4560 1:STN:280:DC%2BD28vltVyqtA%3D%3D 16874872
8. ES Huebner CM Surawicz 2006 Probiotics in the prevention and treatment of gastrointestinal infections Gastroenterol Clin North Am 35 355 365 10.1016/j.gtc.2006.03.005 10.1016/j.gtc.2006.03.005 16880070 (Pubitemid 44118667)
9. F Yan DB Polk 2006 Probiotics as functional food in the treatment of diarrhea Curr Opin Clin Nutr Metab Care 9 717 721 10.1097/01.mco.0000247477. 02650.51 10.1097/01.mco.0000247477.02650.51 17053425 (Pubitemid 44624619)
10. KC Johnson-Henry JD Riff M Gordanpour PM Sherman 2005 Probiotics in models of gastrointestinal infections Nutrafoods 4 29 36
11. M Medici CG Vinderola R Weill G Perdigon 2005 Effect of fermented milk containing probiotic bacteria in the prevention of an enteroinvasive Escherichia coli infection in mice J Dairy Res 72 243 249 10.1017/S0022029905000750 10.1017/S0022029905000750 1:CAS:528:DC%2BD2MXjtVWnsbk%3D 15909691 (Pubitemid 40689754)
12. FS Martins RM Nardi RM Arantes CA Rosa MJ Neves JR Nicoli 2005 Screening of yeasts as probiotic based on capacities to colonize the gastrointestinal tract and to protect against enteropathogen challenge in mice J Gen Appl Microbiol 51 83 92 10.2323/jgam.51.83 10.2323/jgam.51.83 1:CAS:528: DC%2BD2MXlsVygurs%3D 15942869 (Pubitemid 40895065)
13. NB Correa LA Peret Filho FJ Penna FM Lima JR Nicoli 2005 A randomized formula controlled trial of Bifidobacterium lactis and Streptococcus thermophilus for prevention of antibiotic-associated diarrhea in infants J Clin Gastroenterol 39 385 389 10.1097/01.mcg.0000159217.47419.5b 10.1097/01.mcg. 0000159217.47419.5b 15815206 (Pubitemid 40548075)
14. RB Canani P Cirillo G Terrin L Cesarano MI Spagnuolo A De Vincenzo F Albano A Passariello G De Marco F Manguso A Guarino 2007 Probiotics for treatment of acute diarrhoea in children: randomised clinical trial of five different preparations BMJ 335 340 345 10.1136/bmj.39272.581736.55 10.1136/bmj.39272.581736.55 17690340 (Pubitemid 47310868)
15. JA Drisko CK Giles BJ Bischoff 2003 Probiotics in health maintenance and disease prevention Altern Med Rev 8 143 155 12777160
16. M Hickson AL D'Souza N Muthu TR Rogers S Want C Rajkumar CJ Bulpitt 2007 Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: randomised double-blind placebo controlled trial BMJ 335 80 84 10.1136/bmj.39231.599815.55 10.1136/bmj.39231.599815.55 17604300 (Pubitemid 47123282)
17. K Whelan 2007 Enteral-tube-feeding diarrhoea: manipulating the colonic microbiota with probiotics and prebiotics Proc Nutr Soc 66 299 306 10.1017/S0029665107005551 10.1017/S0029665107005551 17637081 (Pubitemid 47076226)
18. S Sazawal G Hiremath U Dhingra P Malik S Deb RE Black 2006 Efficacy of probiotics in prevention of acute diarrhoea: a meta-analysis of masked, randomised placebo-controlled trials Lancet Infect Dis 6 374 382 10.1016/S1473-3099(06)70495-9 16728323 (Pubitemid 43737276)
19. C De Simone R Vesely BS Bianchi E Jirillo 1993 The role of probiotics in modulation of the immune system in man and in animals Int J Immunother 9 23 28
20. CD Ericsson 2005 Nonantimicrobial agents in the prevention and treatment of traveler's diarrhea Clin Infect Dis 41 557 563 10.1086/432952 10.1086/432952 (Pubitemid 41691587)
21. E Hilton P Kolakowski G Singer M Smith 1997 Efficacy of Lactobacillus GG as a diarrheal preventive in travellers J Travel Med 4 41 43 10.1111/j.1708-8305.1997.tb00772.x 10.1111/j.1708-8305.1997.tb00772.x 9815476
22. PR Marteau M De Vrese CJ Cellier J Schrezenmeir 2001 Protection from gastrointestinal diseases with the use of probiotics Am J Clin Nutr 73 430 436
23. J Saavedra 2000 Probiotics and infectious diarrhea Am J Gastroenterol 95 16 18 10.1016/S0002-9270(99)00811-4 10.1016/S0002-9270(99)00811-4 (Pubitemid 30039354)
24. M Montalto F Arancio D Izzi L Cuoco V Curigliano R Manna G Gasbarrini 2002 Probiotics: history, definition, requirements and possible therapeutic applications Ann Ital Med Int 17 157 165 12402663
25. LJ Fooks GR Gibson 2002 Probiotics as modulators of the gut flora Br J Nutr 88 39 49 10.1079/BJN2002628 10.1079/BJN2002628
26. JA Vanderhoof RJ Young 2001 The role of probiotics in the treatment of intestinal infections and inflammation Curr Opin Gastroenterol 17 58 62 10.1097/00001574-200101000-00011 10.1097/00001574-200101000-00011 1:STN:280:DC%2BD28rpvVOlsA%3D%3D 17031151 (Pubitemid 32098892)
27. SK Lee HJ Kim SG Chi JY Jang KD Nam NH Kim KR Joo SH Dong BH Kim YW Chang JI Lee R Chang 2005 Saccharomyces boulardii activates expression of peroxisome proliferator-activated receptor-gamma in HT-29 cells Korean J Gastroenterol 45 328 334 15908765
28. F Shanahan 2005 Physiological basis for novel drug therapies used to treat the inflammatory bowel diseases I. Pathophysiological basis and prospects for probiotic therapy in inflammatory bowel disease Am J Physiol Gastrointest Liver Physiol 288 417 421 10.1152/ajpgi.00421.2004 10.1152/ajpgi.00421.2004 (Pubitemid 40261738)
29. M Boirivant W Trober 2007 The mechanism of action of probiotics Curr Opin Gastroenterol 23 679 692 10.1097/MOG.0b013e3282f0cffc 10.1097/MOG. 0b013e3282f0cffc 17906447 (Pubitemid 47508800)
30. LV Mc Farland 2007 Meta-analysis of probiotics for the prevention of traveller's diarrhea Travel Med Infect Dis 5 97 105 10.1016/j.tmaid.2005.10.003 10.1016/j.tmaid.2005.10.003 (Pubitemid 46222221)
31. G Villarruel DM Rubio F Lopez J Cintioni R Gurevech G Romero Y Vandenplas 2007 Saccharomyces boulardii in acute childhood diarrhoea: a randomized, placebo-controlled study Acta Paediatr 96 538 541 10.1111/j.1651-2227.2007. 00191.x 10.1111/j.1651-2227.2007.00191.x 17306006 (Pubitemid 46466118)
32. H Szajewska A Skorka M Dylag 2007 Meta-analysis: Saccharomyces boulardii for treating acute diarrhoea in children Aliment Pharmacol Ther 25 257 264 1:STN:280:DC%2BD2s%2FmslShsg%3D%3D 17269987 (Pubitemid 46115395)
33. M Can BA Besirbellioglu IY Avci CM Beker A Pahsa 2006 Prophylactic Saccharomyces boulardii in the prevention of antibiotic-associated diarrhea: a prospective study Med Sci Monit 12 19 22
34. LV Mc Farland P Bernasconi 1993 Saccharomyces boulardii: a review of an innovative biotherapeutic agent Microb Ecol Health Dis 6 157 171 10.3109/08910609309141323
35. JP Buts P Bernasconi MP Van Craynest P Maldague R De Meyer 1986 Response of human and rat small intestinal mucosa to oral administration of Saccharomyces boulardii Pediatr Res 20 192 196 10.1203/00006450-198602000-00020 10.1203/00006450-198602000-00020 1:CAS:528:DyaL28XhtVajs7Y%3D 3080730
36. S Sougioultzis S Simeonidis KR Bhaskar X Chen PM Anton S Keates C Pothoulakis CP Kelly 2006 Saccharomyces boulardii produces a soluble anti-inflammatory factor that inhibits NF-kappaB-mediated IL-8 gene expression Biochem Biophys Res Commun 343 69 76 10.1016/j.bbrc.2006.02.080 10.1016/j.bbrc.2006.02.080 1:CAS:528:DC%2BD28XivVOjsLY%3D 16529714
37. E Isolauri 2003 Probiotics for infectious diarrhoea Gut 52 436 437 10.1136/gut.52.3.436 10.1136/gut.52.3.436 1:STN:280:DC%2BD3s%2FntlCnsw%3D%3D 12584230 (Pubitemid 36250068)
38. S Dahan G Dalmasso V Imbert JF Peyron P Rampal D Czerucka 2003 Saccharomyces boulardii interferes with enterohemorrhagic Escherichia coli-induced signalling pathways in T84 cells Infect Immun 71 766 773 10.1128/IAI.71.2.766-773.2003 10.1128/IAI.71.2.766-773.2003 1:CAS:528: DC%2BD3sXovFSmtA%3D%3D 12540556 (Pubitemid 36150770)
39. PM Sherman KC Johnson-Henry HP Yeung PSC Ngo J Goulet TA Tompkins 2005 Probiotics reduce enterohemorrhagic Escherichia coli O157:H7- and enteropathogenic E. coli O127:H6-induced changes in polarized T84 epithelial cell monolayers by reducing bacterial adhesion and cytoskeletal rearrangements Infect Immun 73 5183 5188 10.1128/IAI.73.8.5183-5188.2005 10.1128/IAI.73.8.5183- 5188.2005 1:CAS:528:DC%2BD2MXmvVCisbc%3D 16041036 (Pubitemid 41105678)
40. K Ishida-Fujii R Sato S Goto XP Yang H Kuboki S Hirano M Sato 2007 Prevention of pathogenic Escherichia coli infection in mice and stimulation of macrophage activation in rats by an oral administration of probiotic Lactobacillus casei I-5 Biosci Biotechnol Biochem 71 866 873 10.1271/bbb.60464 10.1271/bbb.60464 1:CAS:528:DC%2BD2sXltFCns7Y%3D 17420603 (Pubitemid 46650939)
41. KC Johnson-Henry M Nadjafi Y Avitzur DJ Mitchell BY Ngan E Galindo-Mata NL Jones PM Sherman 2005 Amelioration of the effects of Citrobacter rodentium infection in mice by pretreatment with probiotics J Infect Dis 191 2106 2117 10.1086/430318 10.1086/430318 15897997 (Pubitemid 40800582)
42. N Venkatesan V Thiyagarajan S Narayanan A Arul S Raja SGV Kumar T Rajarajan JB Perianayagam 2005 Anti-diarrhoeal potential of Asparagus racemosus wild root extracts in laboratory animals J Pharm Pharm Sci. 8 39 45 1:STN:280:DC%2BD2MzgtV2quw%3D%3D 15946596
43. HR Chitme R Chandra S Kaushik 2004 Studies on anti-diarrheal activity of Calotropis giganta R.BR. in experimental animals J Pharm Pharm Sci 7 70 75 15144737
44. M Uchida Y Kato K Matsueda R Shoda A Muraoka S Yamoto 2000 Involvement of nitric oxide from nerves on diarrhea induced by castor oil in rats Jpn J Pharmacol 82 168 170 10.1254/jjp.82.168 10.1254/jjp.82.168 1:CAS:528: DC%2BD3cXhsVOguro%3D 10877537 (Pubitemid 30153600)
45. N Aikawa K Horikoshi H Maeda H Kobayashi K Ohmori 1999 Antidiarrheal effects of Zaldaride maleate after oral, intravenous and subcutaneous administration to rats Jpn J Pharmacol 81 397 400 10.1254/jjp.81.397 10.1254/jjp.81.397 1:CAS:528:DC%2BD3cXhtFGqtg%3D%3D 10669047 (Pubitemid 30076670)
46. N Mascolo AA Izzo F Barbato F Capasso 1993 Inhibition of nitric oxide synthetase prevent castor oil-induced diarrhea in the rat Br J Pharmacol 108 861 864 1:CAS:528:DyaK3sXisVOgtrc%3D 7683565
47. A Pinto A Calignano N Mascolo G Autore F Capasso 1989 Castor oil increases intestinal formation of platelet-activating factor and acid phosphatase release in the rat Br J Pharmacol 96 872 874 1:CAS:528: DyaL1MXit1Ggs70%3D 2743081
48. N Aikawa A Karasawa 1998 Effects of KW-5617 (Zaldaride maleate), a potent and selective calmodulin inhibitor, on secretory diarrhea and on gastrointestinal propulsion in rats Jpn J Pharmacol 76 199 206 10.1254/jjp.76.199 10.1254/jjp.76.199 1:CAS:528:DyaK1cXht12ntrc%3D 9541283 (Pubitemid 28140413)
49. P Girard Y Pansart MC Coppe JM Gillardin 2005 Saccharomyces boulardii inhibits water and electrolytes changes induced by castor oil in the rat colon Dig Dis Sci 50 2183 2190 10.1007/s10620-005-3029-3 10.1007/s10620-005-3029-3 16240237 (Pubitemid 41504111)
50. P Girard Y Pansart I Lorette JM Gillardin 2003 Dose-response relationship and mechanism of action of Saccharomyces boulardii in castor oil-induced diarrhea in rats Dig Dis Sci 48 770 774 10.1023/A:1022801228938 10.1023/A:1022801228938 1:CAS:528:DC%2BD3sXitFegs7c%3D 12741470 (Pubitemid 36390683)